In vivo anti-tumor effect of hybrid vaccine of dendritic cells and esophageal carcinoma cells on esophageal carcinoma cell line 109 in mice with severe combined immune deficiency

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 8

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

250

HTML

2271

Figures (1-8)

178

Tables (1-1)

159

Sum=2858

Feb 28, 2008 (publication date) through Apr 27, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Esophageal Cancer

World J Gastroenterol. Feb 28, 2008; 14(8): 1167-1174
Published online Feb 28, 2008. doi: 10.3748/wjg.14.1167

Full Size Figure Download Figure

Figure 7 Tumor size (A) and weight (B) in therapeutic group after treatment of EC109-DC, DC, inactivated EC109 and PBS.

Citation: Guo GH, Chen SZ, Yu J, Zhang J, Luo LL, Xie LH, Su ZJ, Dong HM, Xu H, Wu LB. In vivo anti-tumor effect of hybrid vaccine of dendritic cells and esophageal carcinoma cells on esophageal carcinoma cell line 109 in mice with severe combined immune deficiency. World J Gastroenterol 2008; 14(8): 1167-1174
URL: https://www.wjgnet.com/1007-9327/full/v14/i8/1167.htm
DOI: https://dx.doi.org/10.3748/wjg.14.1167